Ingrid advises emerging growth companies across all stages of their lifecycles. Her practice focuses on general corporate counseling, venture capital financings, and mergers and acquisitions. She represents a broad range of technology and life sciences companies, leveraging her experience in strategic M&A and growth-stage private equity to guide clients through complex transactional and strategic matters.

Prior to joining Gunderson Dettmer, Ingrid was an associate at a leading international law firm, where she concentrated on strategic M&A in the healthcare and biotechnology sectors.